Literature DB >> 6812126

Specific action of tranylcypromine to precipitate barbital withdrawal convulsions.

E Tagashira, T Hiramori, T Urano, K Nakao, S Yanaura, Y Kuroiwa.   

Abstract

This research was designed to determine whether the convulsion-eliciting action of tranylcypromine (TCP) during bartibal (B) withdrawal was specific to physical dependence on B, and to compare the findings with the action of pentetrazol (PTZ). Challenge with 15-20 mg/kg IP TCP at 48 or B withdrawal resulted in the elicitation of clonic-tonic convulsion (CTC) in all rats (n = 6) within 10 min. Another challenge with 5-20 mg/kg TCP led to the dose-related precipitation and intensification of CTC. The CTC-inducing action of TCP was relatively reduced as the B withdrawal signs were gradually mitigated. In other words, when challenge with the drug was made at 72h of B withdrawal, the time of CTC onset was prolonged, and the incidence was reduced to 50% in parallel with abolition of the other withdrawal signs. A challenge at 120 h of B withdrawal when the vital signs had almost recovered to prewithdrawal level failed to induce even the prodromal signs of convulsion. In all rats exhibiting only mild to moderate withdrawal signs (such as hyperirritability, hyper-reflexia, anorexia, weight loss), 40 mg/kg TCP was required to induce CTC during B withdrawal, which was twice the dose required in severely dependent rats. Other monoamine oxidase inhibitors, i.e., pargyline, iproniazid, and clorgyline, elicited no CTC during B withdrawal. Methamphetamine was without effect on B withdrawal convulsions. From these findings, the convulsive threshold for TCP during B withdrawal proved well correlated to the grade of B-dependence and the duration of B-withdrawal signs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812126     DOI: 10.1007/bf00431928

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  (-)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system.

Authors:  A R Green; D G Grahame-Smith
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

2.  Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain.

Authors:  H GREEN; R W ERICKSON
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-02-01

3.  Anticonvulsant properties of monoamine oxidase inhibitors.

Authors:  D J PROCKOP; P A SHORE; B B BRODIE
Journal:  Ann N Y Acad Sci       Date:  1959-09-17       Impact factor: 5.691

4.  [Influence of changes of serotonin content of the central nervous system on the seizure threshold of cardiazol].

Authors:  W KOBINGER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1958

5.  Studies on hyperactivity in rats given tranylcypromine stereoisomers and reserpine.

Authors:  D F Smith
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-09

6.  The effect of withdrawal from cannabis on pentylenetetrazol convulsive threshold in mice.

Authors:  G B Chesher; D M Jackson
Journal:  Psychopharmacologia       Date:  1974

7.  Catecholamine concentration in discrete brain areas following the withdrawal of barbital dependent rats.

Authors:  W W Morgan; K A Pfeil; E G Gonzales
Journal:  Life Sci       Date:  1977-02-01       Impact factor: 5.037

8.  Tranylcypromine stereoisomers, monoaminergic neurotransmission and behavior. A minireview.

Authors:  D F Smith
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1980-05

9.  Experimental barbiturate dependence. I. Barbiturate dependence development in rats by drug-admixed food (DAF) method.

Authors:  E Tagashira; T Izumi; S Yanaura
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

10.  Irritable aggression and open field behavior in rats given 2-phenylcyclopropylamines.

Authors:  D F Smith
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.